Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03906435 · ClinicalTrials.gov registry record · NA

Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)

A NA study of Parent-Child Relations and Premature Infant, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03906435: Recruiting NA study of Parent-Child Relations and Premature Infant, sponsored by University of Texas Southwestern Medical Center.

NCT03906435 is a NA study of Parent-Child Relations and Premature Infant that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants, below the 319-participant average among 38 other Parent-Child Relations trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03906435, a NA study of Parent-Child Relations and Premature Infant, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study is being done to see if outcomes for both a premature infant's parents and the infant born prematurely who have spent time in the neonatal intensive care unit (NICU) can be improved through parent cognitive behavioral therapy (CBT) sessions.

Primary Outcome

Measures parental perceptions of child vulnerability. It has been used for parents with infants as young as 10-12 weeks of age up through 6 months to a year old. It is a 10 question scale, with each question scored on a five point likert scale (1-5). Score range is 10-50. Maximum score of 50 possible. A score of 27 or more was the median score for a sample of medically fragile neonates, and signifies relatively high perceptions of vulnerability. While a score of 23 was the median for a sample of

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Study Locations (1)

Texas

  • Parkland Health & Hospital System - Dallas

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-04-15
Est. Completion 2026-12-01
Phase NA

What NCT03906435 shows while recruiting

NCT03906435 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 319-participant average among 38 other Parent-Child Relations trials with a reported enrollment target (69% lower).

The record links to 4 conditions, with Parent-Child Relations appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT03906435 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03906435 about?

NCT03906435 is a clinical study titled "Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)". This study is being done to see if outcomes for both a premature infant's parents and the infant born prematurely who have spent time in the neonatal intensive care unit (NICU) can be improved through parent cognitive behavioral therapy (CBT) sessions.

What is the current status of trial NCT03906435?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-04-15. Estimated completion is 2026-12-01.

What conditions does trial NCT03906435 study?

This clinical trial studies the following conditions: Parent-Child Relations, Premature Infant, Development, Child, Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse).

What interventions are being tested in trial NCT03906435?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03906435?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03906435 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parent-Child Relations

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03906435's enrollment target sits among peer trials

100 22nd of 38 higher than 16 of 38 other Parent-Child Relations trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parent-Child Relations trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03906435, the US trial registry maintained by the National Library of Medicine. NCT03906435 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.